News

• FDA accepts Alzheimer drug for traditional approval path
  03/06/2023 / 05:18 - TeleTrader
•  
• Wall Street closes higher after data, earnings
  02/15/2023 / 22:01 - TeleTrader
•  
• Biogen's Q4 EPS surges 52% to $3.79
  02/15/2023 / 13:00 - TeleTrader
•  
• FDA approves drug for early Alzheimer's treatment
  01/06/2023 / 21:10 - TeleTrader
•  
• Wall Street extends losses on rate talks, China unrest
  11/28/2022 / 19:15 - TeleTrader
•  
• Biogen falls 5% after death in Alzheimer's drug trial
  11/28/2022 / 13:40 - TeleTrader
•  
• Biogen's EPS sees annual jump of 253% in Q3
  10/25/2022 / 13:05 - TeleTrader
•  
• US closes volatile session with gains after CPI data
  10/13/2022 / 22:01 - TeleTrader
•  
• Wall Street extends gains Dow surges 500 points
  09/28/2022 / 19:15 - TeleTrader
•  
• US mixed at open amid interest rate talks
  09/28/2022 / 15:30 - TeleTrader
•  
• US closes lower on data reports
  08/01/2022 / 22:00 - TeleTrader
•  
• US opens mostly flat amid data, earnings
  07/20/2022 / 15:30 - TeleTrader
•  
• Biogen's Q2 EPS soar by 142.14% to $7.24 per share
  07/20/2022 / 13:01 - TeleTrader
•  
• US higher premarket ahead of data, earnings
  07/20/2022 / 10:33 - TeleTrader
•  
• Biogen revenue slips 6% to $2.53B in Q1
  05/03/2022 / 13:09 - TeleTrader